NFKBID and infectious disease: In any case, as we identified IκBNS as driver of inflammation and immunopathology in infection-associated inflammation, it may constitute an interesting pharmaceutical target to prevent exaggerated pro-inflammatory immunity and severe outcome of infectious diseases.